Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Qiuxing Yang"'
Autor:
Jing Guo, Qiuxing Yang, Sheng Wei, Jingjing Shao, Tianye Zhao, Liyuan Guo, Jia Liu, Jia Chen, Gaoren Wang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background The role of the PRDM5 in esophageal squamous cell carcinoma (ESCC) has not been revealed. This study investigated the relationship between PRDM5 expression and survival outcome in esophageal squamous cell carcinoma and explored th
Externí odkaz:
https://doaj.org/article/4c360eff0d944bc59f3b20f006f3cb7d
Autor:
Qiuxing Yang1 yangqx@ntu.edu.cn, Bo Cai2, Shudong Zhu1, Guomei Tai3, Aiguo Shen1 aiguoshen_nt@126.com
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 16, p5351-5366. 16p.
Publikováno v:
Journal of Oncology. 2022:1-12
The number of programmed cell death protein 1 (PD-1) inhibitors is gradually increasing; this study aimed to comprehensively and systematically evaluate the impact of PD-1 inhibitors as second-line therapy for terminal or metastatic esophageal cancer
Publikováno v:
Journal of Inflammation Research.
Mingde Gao1 *, Qiuxing Yang2 *, Haifei Xu,1 Zhigang Chen,1 Xiaolin Wang,1 Haifeng Guo1 1Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, Peopleâs Republic of China; 2Depart
Publikováno v:
Nutrition and cancer. 74(9)
Many studies have reported that the geriatric nutritional risk index (GNRI) and C-reactive protein to albumin ratio (CAR) may be associated with prognosis of esophageal cancer (EC); however, the results are inconsistent. Therefore, we performed a met
Publikováno v:
Br J Radiol
Objective The present study explored the value of preoperative CT radiomics in predicting lymphovascular invasion (LVI) in esophageal squamous cell carcinoma (ESCC). Methods A retrospective analysis of 294 pathologically confirmed ESCC patients under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169261e6b90e3e70c974b09a75bea96b
https://europepmc.org/articles/PMC8822548/
https://europepmc.org/articles/PMC8822548/
Background: Postoperative recurrence of esophageal squamous cell carcinoma is an important factor affecting the survival of patients. Hypercoagulability is a related factor for the recurrence of esophageal squamous cell carcinoma. Fibrinogen/platelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14236c1dfe43cc16d7563f127f1c1a74
https://doi.org/10.21203/rs.3.rs-870794/v1
https://doi.org/10.21203/rs.3.rs-870794/v1
Publikováno v:
Virchows Archiv : an international journal of pathology. 479(5)
Esophageal squamous cell carcinoma (ESCC) is one of the most common malignant tumors in East Asia. Surgical resection is currently the typical treatment. However, due to the highly invasive and metastatic characteristic of the disease, the mortality